Compare KARO & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KARO | TNDM |
|---|---|---|
| Founded | 2001 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | 2013 |
| Metric | KARO | TNDM |
|---|---|---|
| Price | $47.48 | $15.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 19 |
| Target Price | ★ $59.33 | $28.00 |
| AVG Volume (30 Days) | 92.8K | ★ 2.5M |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $22.17 | $8.11 |
| Revenue Next Year | $16.74 | $11.85 |
| P/E Ratio | $24.13 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $41.25 | $10.00 |
| 52 Week High | $60.95 | $29.65 |
| Indicator | KARO | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 41.27 |
| Support Level | $43.31 | $12.75 |
| Resistance Level | $47.92 | $15.75 |
| Average True Range (ATR) | 2.34 | 1.29 |
| MACD | -0.21 | 0.03 |
| Stochastic Oscillator | 53.33 | 37.71 |
Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.